NEWS - Earnings Call and corporate updates.. anyone reading and thinking about investing should listen in on this call, im sure there's something good.
Brainstorm to Host Second-Quarter 2017 Earnings Teleconference and Provide Important Corporate Updates, on Wednesday, August 16
HACKENSACK, N.J. and PETACH TIKVAH, Israel, Aug. 10, 2017 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, will announce financial results for the three and six months ended June 30, 2017 and provide important corporate updates on Wednesday, August 16th.
BrainStorm Cell Therapeutics
Wednesday, August 16, 2017 @ 8:30am Eastern Time Toll Free: 877-718-5095 Israel Investors: 1 80 924 6042 International: 913-312-0381 Conference ID: 1392963 Webcast: http://public.viavid.com/index.php?id=125868
Replays, available through August 30, 2017 Toll Free: 844-512-2921 International: 412-317-6671 Conference ID: 1392963
About BrainStorm Cell Therapeutics Inc. BrainStorm Cell Therapeutics Inc. is a biotechnology company engaged in the development of first-of-its-kind adult stem cell therapies derived from autologous bone marrow cells for the treatment of neurodegenerative diseases. The Company holds the rights to develop and commercialize its NurOwn® technology through an exclusive, worldwide licensing agreement with Ramot, the technology transfer company of Tel Aviv University. NurOwn has been administered to approximately 75 patients with ALS in clinical trials conducted in the United States and Israel. In a randomized, double-blind, placebo-controlled clinical trial conducted in the U. S., a clinically meaningful benefit was demonstrated by higher response to NurOwn compared with placebo. For more information, visit the company's website at www.brainstorm-cell.com.
CONTACTS
Media: Uri Yablonka Chief Business Officer Brainstorm Cell Therapeutics Inc. Phone: (646) 666-3188 uri@brainstorm-cell.com
Investors: Michael Rice LifeSci Advisors, LLC Phone: 646-597-6979 mrice@lifesciadvisors.com